Episodebeskrivelse
Fresh off Pfizer's (PFE) $10 billion battle to acquire Metsera (MTSR), Pfizer chairman and CEO Albert Bourla tells Yahoo Finance Executive Editor Brian Sozzi that the future for the pharmaceutical giant is bright. The company plans to enter the GLP-1 space by 2028 and aims to become a leader in the obesity market.
Bourla also notes that the next big breakthrough in medicine could be aided by the use of artificial intelligence and discusses Pfizer's relationship with the White House.
For full interviews, highlights, and key insights, check out more from Yahoo Finance Invest.

